Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus

Autor: Hundscheid, T., Onland, W., Kooi, E.M.W., Vijlbrief, D.C., Vries, W.B. de, Dijkman, K.P., Kaam, A.H. van, Villamor, E., Kroon, A.A., Visser, R., Mulder-de Tollenaer, S.M., Bisschop, B. de, Dijk, P.H., Avino, D., Hocq, C., Zecic, A., Meeus, M., Baat, T. de, Derriks, F., Henriksen, T.B., Kyng, K.J., Donders, R., Nuytemans, D.H.G.M., Overmeire, B. van, Mulder, A.L., Boode, W.P. de, BeNeDuctus Trial Investigators

Publikováno v: The New England journal of medicine, 388(11), 980-990. Massachussetts Medical Society
New England Journal of Medicine, 388(11), 980-990. MASSACHUSETTS MEDICAL SOCIETY
Hundscheid, T, Onland, W, Kooi, E M W, Vijlbrief, D C, de Vries, W B, Dijkman, K P, van Kaam, A H, Villamor, E, Kroon, A A, Visser, R, Mulder-de Tollenaer, S M, De Bisschop, B, Dijk, P H, Avino, D, Hocq, C, Zecic, A, Meeus, M, de Baat, T, Derriks, F, Henriksen, T B, Kyng, K J, Donders, R, Nuytemans, D H G M, Van Overmeire, B, Mulder, A L, de Boode, W P & BeNeDuctus Trial Investigators 2023, ' Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus ', The New England Journal of Medicine, vol. 388, no. 11, pp. 980-990 . https://doi.org/10.1056/NEJMoa2207418
The New England journal of medicine
Hundscheid, T, Onland, W, Kooi, E M W, Vijlbrief, D C, de Vries, W B, Dijkman, K P, van Kaam, A H, Villamor, E, Kroon, A A, Visser, R, Mulder-de Tollenaer, S M, de Bisschop, B, Dijk, P H, Avino, D, Hocq, C, Zecic, A, Meeus, M, de Baat, T, Derriks, F, Henriksen, T B, Kyng, K J, Donders, R, Nuytemans, D H G M, van Overmeire, B, Mulder, A L & de Boode, W P 2023, ' Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. ', The New England journal of medicine, vol. 388, no. 11, pp. 980-990 . https://doi.org/10.1056/NEJMoa2207418
The New England Journal of Medicine, 388, 980-990
New England Journal of Medicine. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine
The New England Journal of Medicine, 388, 11, pp. 980-990

Contains fulltext : 290809.pdf (Publisher’s version ) (Closed access) BACKGROUND: Cyclooxygenase inhibitors are commonly used in infants with patent ductus arteriosus (PDA), but the benefit of these drugs is uncertain. METHODS: In this multicenter,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8cba6fec11dfcccb4e75dd934a2c6cf
https://doi.org/10.1056/NEJMoa2207418

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prognostic model for predicting survival in very preterm infants: an external validation study

Autor: Beek, P.E. van, Groenendaal, F., Onland, W., Koole, S., Dijk, P.H., Dijkman, K.P., Dungen, F. van den, Heijst, A. van, Kornelisse, R.F., Schuerman, F., Westering-Kroon, E. van, Witlox, R.S.G.M., Andriessen, P., Schuit, E., EPI-DAF Study Grp

Publikováno v: BJOG: An International Journal of Obstetrics and Gynaecology, 129(4), 529-538. Wiley-Blackwell Publishing Ltd
BJOG: An International Journal of Obstetrics and Gynaecology. Wiley Online Library
BJOG: An International Journal of Obstetrics and Gynaecology, 129(4), 529-538. WILEY
BJOG: An International Journal of Obstetrics and Gynaecology. Wiley-Blackwell
BJOG : An International Journal of Obstetrics and Gynaecology, 129(4), 529-538. Wiley-Blackwell
EPI-DAF study group 2021, ' Prognostic model for predicting survival in very preterm infants : an external validation study ', BJOG: An International Journal of Obstetrics and Gynaecology . https://doi.org/10.1111/1471-0528.17010
Bjog-an International Journal of Obstetrics and Gynaecology, 129(4), 529-538. Wiley
BJOG-an International Journal Of Obstetrics And Gynaecology, 129(4), 529-538. Wiley

Objective: To perform a temporal and geographical validation of a prognostic model, considered of highest methodological quality in a recently published systematic review, for predicting survival in very preterm infants admitted to the neonatal inten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b8fb574bf76f63531c28c612c062bc0
https://pure.eur.nl/en/publications/093a12f1-30ed-48de-b9d0-777959be80c3

Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia

Autor: Favie, L.M.A., Groenendaal, F., Broek, M.P.H. van den, Rademaker, C.M.A., Haan, T.R. de, Straaten, H.L.M. van, Dijk, P.H., Heijst, A. van, Simons, S.H.P., Dijkman, K.P., Rijken, M., Zonnenberg, I.A., Cools, F., Zecic, A., Lee, J.H. van der, Nuytemans, D.H.G.M., Bel, F. van, Egberts, T.C.G., Huitema, A.D.R., Brouwer, M.J., Mulder-de Tollenaer, S.M., Jebbink-Akkerman, L.J.M.G., Liem, D., Steiner, K., Dudink, J., Jonge, R.C.J. de, Bos, A.A., Sonnaert, M., Camfferman, F.A., PharmaCool Study Grp

Publikováno v: Favié, L M A, Groenendaal, F, van den Broek, M P H, Rademaker, C M A, de Haan, T R, van Straaten, H L M, Dijk, P H, van Heijst, A, Simons, S H P, Dijkman, K P, Rijken, M, Zonnenberg, I A, Cools, F, Zecic, A, van der Lee, J H, Nuytemans, D H G M, van Bel, F, Egberts, T C G & Huitema, A D R 2019, ' Phenobarbital, midazolam pharmacokinetics, effectiveness, and drug-drug interaction in asphyxiated neonates undergoing therapeutic hypothermia ', Neonatology, vol. 116, no. 2, pp. 154-162 . https://doi.org/10.1159/000499330
Neonatology, 116(2), 154-162. Karger
NEONATOLOGY
Neonatology, 116(2), 154-162
Neonatology, 116, 154-162
Neonatology, 116, 2, pp. 154-162
Neonatology, 116(2), 154. S. Karger AG
Neonatology, 116(2), 154-162. S. Karger AG

Background: Phenobarbital and midazolam are commonly used drugs in (near-)term neonates treated with therapeutic hypothermia for hypoxic-ischaemic encephalopathy, for sedation, and/or as anti-epileptic drug. Phenobarbital is an inducer of cytochrome

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c871f8447881696cdb88d95d5207e3ac
https://hdl.handle.net/1887/120506

Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia

Autor: Favie, L.M.A., Groenendaal, F., Broek, M.P.H. van den, Rademaker, C.M.A., Haan, T.R. de, Straaten, H.L.M. van, Dijk, P.H., Heijst, A. van, Dudink, J., Dijkman, K.P., Rijken, M., Zonnenberg, I.A., Cools, F., Zecic, A., Lee, J.H. van der, Nuytemans, D.H.G.M., Bel, F. van, Egberts, T.C.G., Huitema, A.D.R., Brouwer, M.J., Mulder-de Tollenaer, S.M., Jebbink-Akkerman, L.J.M.G., Liem, D., Steiner, K., Simons, S.H.P., Jonge, R.C.J. de, Bos, A.A., Sonnaert, M., Camfferman, F.A., PharmaCool Study Grp

Publikováno v: PLoS One, 14
PLoS ONE, Vol 14, Iss 2, p e0211910 (2019)
PLoS One, 14, 2
PLoS ONE
PLoS ONE, 14(2):e0211910. Public Library of Science
PLoS One, 14(2). Public Library of Science
PLoS ONE, 14(2), e0211910. Public Library of Science
PLOS ONE
PLoS One (online), 14(2):e0211910. Public Library of Science
Favié, L M A, Groenendaal, F, van den Broek, M P H, Rademaker, C M A, de Haan, T R, van Straaten, H L M, Dijk, P H, van Heijst, A, Dudink, J, Dijkman, K P, Rijken, M, Zonnenberg, I A, Cools, F, Zecic, A, van der Lee, J H, Nuytemans, D H G M, van Bel, F, Egberts, T C G, Huitema, A D R & the PharmaCool study group 2019, ' Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia ', PLoS ONE, vol. 14, no. 2, e0211910 . https://doi.org/10.1371/journal.pone.0211910
PLoS ONE, 14(2)

ObjectiveMorphine is a commonly used drug in encephalopathic neonates treated with therapeutic hypothermia after perinatal asphyxia. Pharmacokinetics and optimal dosing of morphine in this population are largely unknown. The objective of this study w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7409ba509956e5ed0239c3c5e646146c
http://hdl.handle.net/2066/202110